克罗西通过Ca2+/PLC/IP3和TNF通路抑制了依赖性巨细胞的直接类型的过敏反应
Ting Fan1, Kai Jiang1, Zixiao Wang1
1Department of Clinical Pharmacy, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
International immunopharmacology
|January 29, 2024
概括
克罗西,来自色红花,通过抑制免疫球蛋白E (IgE) 介导反应,显示出显著的抗过敏作用. 它通过阻断涉及TNF和信号的关键通路而起作用,提供潜在的治疗益处.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 自然产品 自然产品
背景情况:
- 克罗塞是一种来自Crocus sativus L.的天然化合物,具有已知的抗氧化和抗心血管作用.
- 它的潜在抗过敏特性以前没有被研究过.
研究的目的:
- 研究克罗塞丁对免疫球蛋白E (IgE) 介导的过敏反应的抑制作用.
- 阐明克罗西抗过敏活性的潜在机制.
主要方法:
- 在体内研究中使用被动皮肤过敏反应 (PCA) 来评估抗过敏作用.
- 试验室方法包括RBL-2H3细胞上的脱粒试验,成像和细胞因子释放试验.
- 用RNA测序来识别受克罗西影响的分子通路.
主要成果:
- 克罗塞丁在体外和体内显著抑制了IgE介导的脱粒和过敏反应.
- RNA-seq分析显示,TNF通路受到克罗西的抑制.
- 克罗塞丁抑制了RBL-2H3细胞中IgE介导的流和PLC/IP3的酸化.
结论:
- 克罗塞丁对IgE介导反应表现出强大的抗过敏活性.
- 抗过敏机制涉及TNF和Ca2+/PLC/IP3信号通路的抑制.
相关概念视频
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K
Inflammation
53.4K
Overview
53.4K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K


